Urol. praxi, 2013; 14(4): 184-186
Occurence of prostate cancer in patiens with PSA level < 4 ng/ml
- Urologická klinika LF UP a FN Olomouc
The study is focusing on prostate cancer detection in patiens with serum PSA (prostate- specific antigen) level behind 4 ng/ml. The aim
is to assess the aggressiveness of detected tumours and on the base of this data make some recommendation to the „threshold“ PSA
level for prostate biopsy indication..
Keywords: prostate cancer, low level of PSA
Published: October 27, 2013 Show citation
References
- Študent V, Grepl M, Král M, Hartmann I. Má vyšetření PSA stále význam při vyhledávání karcinomu prostaty? Urol. praxi 2006; 5: 214-218.
- Balík M, Broďák M. Lokalizovaný karcinom prostaty - diagnostika a léčba. Urol. praxi 2011; 12(2): 105-110.
- Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level <= 4ng per milliliter. N Engl J Med 2004; 350: 2239-2246.
Go to original source... 
Go to PubMed... - Bonet M, Merglen A, Fioretta G, et al. Characteristics and outcome of prostate cancer with PSA < 4 ng/ml at diagnosis: a population-based study. Clin Transl Oncol 2009; 11: 312-317. Go to original source... Go to PubMed...
- Bul M, van Leeuwen PJ, Zhu X, et al. Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3 ng/ml who are participating in ERSPC Rotterdam. Eur Urol 2011; 59: 498-505. Go to original source... Go to PubMed...
- Grepl M, Král M, Burešová E, Študent V. Agresivní karcinom prostaty u pacientů s nízkým PSA. Ces Urol 2010; 14(1): 48-54.
- Schroder FH, Bangma ChH, Roobol MJ. It is necessary to detect all prostate cancers in men with serum PSA levels < 3 ng/ml? A comparison of biopsy results of PCPT atd outcome-related information from ERSPC. Eur Urol 2008; 53: 901-908. Go to original source... Go to PubMed...